The cellgorithm platform cell therapy market was valued at USD 814.0 million in 2025 and is forecast to register a 17.5% CAGR between 2026 and 2036. In 2026, autologous cell therapy holds 39.0% of the therapy type category, oncology represents 37.3% of application demand and hospitals account for 31.7% of end user sales.